Driving Healthcare Performance in Taiwan
Established in Taipei in 1982, IMS Health Taiwan has one of the most comprehensive offering portfolios in the region, with solutions for local companies and affiliates of multinational companies in the life sciences industry including market data (sell-out, sell-in and prescription data services), primary market research, commercial effectiveness services and consulting services.
IMS Health is the leading pharmaceutical market information provider with more than 100 affiliates around the world. In Taiwan, our data and research scopes cover hospital, drug store and clinic channels. As a result of continuous efforts made since 1983, IMS Health local audits have become an indispensable reference tool for researchers, marketers and senior management to analyze market dynamics, forecast future trends, and monitor business effectiveness among others.
With the robust growth of the oncology business in Taiwan, we brought in Oncology Analyzer (OA) in 2008 to support our clients in getting a profound understanding of prescription behavior, prescription dynamics, treatment flows, and others.
Moving forward to 2014 and beyond, IMS Health Taiwan will take a step ahead to enhance the quality of IMS Health local audits and OA, as well as integrate all IMS Health offerings and services to provide real solutions, and introduce new businesses such as IMS Consumer Health Analysis and Health Economics and Outcome Research (HEOR) to meet emerging client needs.